Fourteen゛nd Ten〥ay Tegoprazan–Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy forHelicobacter pyloriEradication—A Noninferiority, Multicenter, Randomized Controlled Trial

Post time 3 day(s) ago

journal：Journal of Gastroenterology and Hepatology

Authors：Yan Fan; Chuanfei Li; Wenguang Zhang; Jinlian Shi; Renzheng Liang; Meng Deng; Shengtao Liao; Xiao Xiao; Ke Zhan; Liewang Qiu; Zhechuan Mei; Lin Lv

Published date：2026-2-

DOI：10.1111/jgh.70180

PDF link：https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jgh.70180

Article link：https://doi.org/10.1111/jgh.70180

Article Source：Wiley。

Remark：

Post time 3 day(s) ago

: Waiting for confirmation
If the PDF has not been accepted after 72 hours, the system will automatically adopt it.

[Wiley] Fourteen゛nd Ten〥ay Tegoprazan–Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy forHelicobacter pyloriEradication—A Noninferiority, Multicenter, Randomized Controlled Trial

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Wiley] Fourteen゛nd Ten〥ay Tegoprazan–Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy forHelicobacter pyloriEradication—A Noninferiority, Multicenter, Randomized Controlled Trial Copy

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Wiley] Fourteen゛nd Ten〥ay Tegoprazan–Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy forHelicobacter pyloriEradication—A Noninferiority, Multicenter, Randomized Controlled Trial